激肽释放酶、激肽与血压——血管紧张素转换酶抑制的作用 - Suppr | 超能文献

Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.

作者信息

Johnston C I, Clappison B, McGrath B P, Matthews P G, Millar J A, Anderson W P

出版信息

Prog Biochem Pharmacol. 1980;17:123-33.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.激肽释放酶、激肽与血压——血管紧张素转换酶抑制的作用

Prog Biochem Pharmacol. 1980;17:123-33.

2

Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.卡托普利和依那普利对缺钠犬钠排泄及血压的影响。

Fed Proc. 1984 Apr;43(5):1336-41.

3

[Pharmacological effects of captopril].

Nouv Presse Med. 1981 Apr 30;10(19):1531-46.

4

Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.卡托普利治疗原发性高血压。与肾素-血管紧张素-醛固酮系统及激肽释放酶-激肽系统相关的作用

Acta Med Scand Suppl. 1981;646:98-105.

5

Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.在清醒高血压大鼠中，静脉输注沙拉新或卡托普利12小时对血压的影响。与血浆肾素、高血压病程以及解除夹闭的效应的关系。

J Lab Clin Med. 1981 Aug;98(2):302-10.

6

Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).

Adv Exp Med Biol. 1979;120B:447-57.

7

Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.血管紧张素抑制剂在阐明肾素-血管紧张素系统功能中的作用概述。

Prog Biochem Pharmacol. 1980;17:29-35.

8

Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.高血压筛查及使用血管紧张素抑制剂进行治疗。沙拉新和卡托普利。

Postgrad Med. 1980 Oct;68(4):89-92, 94-5, 98.

9

Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.三种结构不同的血管紧张素转换酶抑制剂（卡托普利、SA - 446和MK - 421）对血压、肾素 - 血管紧张素系统和激肽释放酶 - 激肽系统急性作用的比较。

Nihon Jinzo Gakkai Shi. 1985 Mar;27(3):337-42.

10

Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.激肽释放酶-激肽系统和肾素-血管紧张素系统在原发性高血压患者中血管紧张素I转换酶抑制剂降压机制中的意义

Adv Exp Med Biol. 1989;247A:39-48. doi: 10.1007/978-1-4615-9543-4_7.

引用本文的文献

1

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.转换酶抑制的药效学：MK421（依那普利）和MK521的心血管、内分泌及自主神经效应

Br J Clin Pharmacol. 1982 Sep;14(3):347-55. doi: 10.1111/j.1365-2125.1982.tb01990.x.

2

Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.高血压和充血性心力衰竭患者对特定肾素-血管紧张素抑制剂的血流动力学反应。综述。

Drugs. 1984 Aug;28(2):144-69. doi: 10.2165/00003495-198428020-00004.

3

Urinary kallikrein excretion during inhibition of endogenous angiotensin II in the pig.猪体内内源性血管紧张素II受抑制期间的尿激肽释放酶排泄情况

Br J Pharmacol. 1986 Jul;88(3):569-76. doi: 10.1111/j.1476-5381.1986.tb10237.x.